+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Medical & Recreational Marijuana Market - Global Forecast 2026-2032- Product Image
Medical & Recreational Marijuana Market - Global Forecast 2026-2032- Product Image
Sale

Medical & Recreational Marijuana Market - Global Forecast 2026-2032

  • Report

  • 199 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6283163
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Medical and Recreational Marijuana: Executive Overview

Medical and recreational marijuana operates at the intersection of public health, consumer regulation, agriculture, pharmaceuticals, and criminal-justice policy. Its development is shaped by differing national rules for medical access, adult use, cultivation, possession, product testing, advertising, taxation, and cross-border trade. A useful assessment therefore distinguishes regulated medical programs from adult-use frameworks and recognizes that legal status, enforcement practice, and patient access can vary substantially within the same region.

Regulatory Change Is Reshaping the Marijuana Landscape

The sector is undergoing a regulatory transition from prohibition-oriented models toward a mixture of medical authorization, decriminalization, pilot programs, and controlled adult-use systems. This shift places greater emphasis on licensing, traceability, laboratory testing, packaging, age verification, responsible-use communications, and restrictions on impaired driving. Policymakers are also balancing access for patients and consumers with concerns regarding youth exposure, dependency, workplace safety, environmental impacts, and the diversion of legal products into illicit channels.

Artificial Intelligence Strengthens Compliance, Research, and Operations

Artificial intelligence can support the sector through demand and inventory analysis, laboratory anomaly detection, cultivation monitoring, predictive maintenance, customer-service automation, and review of regulatory documentation. In medical applications, data tools may help organize patient records and identify research patterns, but they do not replace clinical judgment or controlled evidence. Responsible deployment requires validated datasets, privacy safeguards, explainability, cybersecurity, human oversight, and controls against biased recommendations or inaccurate health claims.

Regional Insights: Divergent Rules Define North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific

North America has prominent medical and adult-use policy experimentation, although rules differ across jurisdictions and federal, state, provincial, or territorial authorities. Latin America includes medical reforms, decriminalization debates, and cultivation-policy variation, with implementation often influenced by public-health and rural-development priorities. Europe combines established medical access in some countries with cautious adult-use pilots or limited reforms, while the European Union remains a multi-jurisdictional regulatory environment. The Middle East generally maintains restrictive approaches, with limited exceptions and strong controls. Africa shows uneven movement toward medical programs, industrial cultivation, and export-oriented frameworks. Asia-Pacific spans highly restrictive systems, regulated medical access, traditional-use contexts, and selected reform efforts, making local law and enforcement conditions especially important.

Group Insights: Economic and Security Alliances Follow Different Policy Paths

ASEAN members generally reflect cautious and uneven approaches, with national rules ranging from strict prohibition to tightly controlled medical or industrial exceptions. BRICS countries encompass substantial diversity, including medical reforms, cultivation policies, decriminalization discussions, and restrictive regimes. European Union members must navigate national policy choices alongside shared principles affecting product standards, trade, and public health. G7 governments have supported varying combinations of medical access, decriminalization, enforcement, and controlled adult use. GCC states generally maintain restrictive frameworks, while NATO members demonstrate considerable variation because alliance membership does not establish a common marijuana policy.

Country Insights: National Frameworks Range from Medical Access to Strict Prohibition

Australia has developed regulated medical access alongside tightly controlled prescribing and cultivation requirements. Brazil permits defined medical and judicially recognized pathways while maintaining significant restrictions. Canada operates a national legal framework for medical and adult use with provincial and territorial administration. China maintains restrictive controls, despite industrial-hemp activity under specific rules. France, Germany, Italy, Spain, and the United Kingdom have established or evolving medical pathways, with adult-use policy differing by country and, in some cases, undergoing reform. India combines legal restrictions with state-level variation and traditional-use considerations. Japan and South Korea maintain highly controlled environments, including strict rules affecting imported or prescribed products. Mexico has pursued medical and broader reform measures amid continuing legal and implementation uncertainty. Russia retains a restrictive national position. The United States combines state-level medical and adult-use systems with continuing federal constraints, producing complex compliance conditions.

Industry Leaders Should Prioritize Compliance, Evidence, and Responsible Access

Leaders should build jurisdiction-specific compliance systems rather than rely on a single global playbook. Priorities include documented quality management, independent laboratory controls, end-to-end traceability, age and identity safeguards, adverse-event reporting, secure data governance, and clear separation between medical claims and consumer marketing. Organizations should engage regulators and healthcare professionals early, invest in clinical and safety evidence, train staff on responsible use, and prepare for product recalls or regulatory changes. Scenario planning should cover changes in licensing, taxation, enforcement, product standards, and banking or payment access, while partnerships should be evaluated for governance quality as carefully as for commercial capability.

Research Methodology: Comparative Review of Regulation, Public Health, and Industry Practice

This executive summary uses a comparative, desk-based framework focused on medical and recreational marijuana policy and operating conditions. Analysis should triangulate primary legislation, official regulatory guidance, public-health publications, court or administrative decisions, customs and enforcement materials, and peer-reviewed research. Countries and groupings are assessed across legal status, patient access, adult-use permissions, cultivation and manufacturing rules, testing, distribution, advertising, taxation, enforcement, and implementation maturity. Because laws and guidance change frequently, findings should be date-stamped, jurisdiction-specific, and validated against authoritative sources before operational or clinical decisions are made. No market estimates, shares, forecasts, or company-specific claims are used.

Conclusion: Sustainable Progress Depends on Evidence-Based, Jurisdiction-Specific Governance

Medical and recreational marijuana is defined less by a single global model than by a patchwork of national and subnational frameworks. The most durable progress will depend on credible evidence, consistent product quality, effective prevention measures, transparent enforcement, and access pathways that reflect medical need without encouraging unsafe consumption. Industry leaders that combine disciplined compliance with responsible innovation, privacy protection, and constructive policy engagement will be better positioned to operate across this evolving landscape.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Medical & Recreational Marijuana Market, by Product Type
7.1. Introduction
7.2. Dried Flower / Herb
7.3. Oils & Tinctures
7.4. Capsules & Tablets
7.5. Edibles / Gummies
8. Medical & Recreational Marijuana Market, by THC / CBD Content
8.1. Introduction
8.2. High-THC Products
8.3. High-CBD Products
8.4. Balanced THC-CBD Products
9. Medical & Recreational Marijuana Market, by Formulation
9.1. Introduction
9.2. Isolate-Based Products
9.3. Full-Spectrum Extracts
10. Medical & Recreational Marijuana Market, by Administration Route
10.1. Introduction
10.2. Oral Consumption
10.3. Inhalation / Smoking / Vaping
10.4. Topical Application
11. Medical & Recreational Marijuana Market, by Usage
11.1. Introduction
11.2. Medical Use
11.3. Recreational Use
12. Medical & Recreational Marijuana Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Medical & Recreational Marijuana Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Medical & Recreational Marijuana Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Aurora Cannabis Inc.
16.2. Breathe Life Sciences
16.3. Cannabis Sativa, Inc.
16.4. Canopy Growth Corporation
16.5. Cresco Labs
16.6. Cronos Group Inc.
16.7. Curaleaf Holdings, Inc.
16.8. Green Relief Inc.
16.9. Green Thumb Industries Inc.
16.10. GW Pharmaceuticals plc
16.11. Medical Marijuana, Inc.
16.12. MedMen Enterprises Inc.
16.13. MedReleaf Corporation
16.14. Organigram Global Inc.
16.15. STENOCARE AB
16.16. TerrAscend Corp.
16.17. Tilray Brands Inc.
16.18. Trulieve Cannabis Corporation
16.19. Vivo Cannabis Inc.
16.20. Zenabis Global Inc.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Medical & Recreational Marijuana Market, Years Considered for the Study
FIGURE 2. Global Medical & Recreational Marijuana Market, Research Design
FIGURE 3. Global Medical & Recreational Marijuana Market, Research Framework
FIGURE 4. Global Medical & Recreational Marijuana Market, Data Triangulation
FIGURE 5. Global Medical & Recreational Marijuana Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Medical & Recreational Marijuana Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Medical & Recreational Marijuana Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Medical & Recreational Marijuana Market Size, by THC / CBD Content, 2025 vs 2032 (%)
FIGURE 9. Global Medical & Recreational Marijuana Market Size, by THC / CBD Content, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Medical & Recreational Marijuana Market Size, by Formulation, 2025 vs 2032 (%)
FIGURE 11. Global Medical & Recreational Marijuana Market Size, by Formulation, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Medical & Recreational Marijuana Market Size, by Administration Route, 2025 vs 2032 (%)
FIGURE 13. Global Medical & Recreational Marijuana Market Size, by Administration Route, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Medical & Recreational Marijuana Market Size, by Usage, 2025 vs 2032 (%)
FIGURE 15. Global Medical & Recreational Marijuana Market Size, by Usage, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Medical & Recreational Marijuana Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Medical & Recreational Marijuana Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Medical & Recreational Marijuana Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Medical & Recreational Marijuana Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Medical & Recreational Marijuana Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Medical & Recreational Marijuana Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Medical & Recreational Marijuana Market Segmentation & Coverage
TABLE 2. Global Medical & Recreational Marijuana Market Size, 2017-2032 (USD Million)
TABLE 3. Global Medical & Recreational Marijuana Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Dried Flower / Herb Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Dried Flower / Herb Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Dried Flower / Herb Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Oils & Tinctures Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Oils & Tinctures Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Oils & Tinctures Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Capsules & Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Capsules & Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Capsules & Tablets Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Edibles / Gummies Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Edibles / Gummies Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Edibles / Gummies Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Medical & Recreational Marijuana Market Size, by THC / CBD Content, 2017-2032 (USD Million)
TABLE 17. Global High-THC Products Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global High-THC Products Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global High-THC Products Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global High-CBD Products Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global High-CBD Products Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global High-CBD Products Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Balanced THC-CBD Products Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Balanced THC-CBD Products Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Balanced THC-CBD Products Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Medical & Recreational Marijuana Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 27. Global Isolate-Based Products Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Isolate-Based Products Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Isolate-Based Products Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Full-Spectrum Extracts Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Full-Spectrum Extracts Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Full-Spectrum Extracts Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Medical & Recreational Marijuana Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 34. Global Oral Consumption Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Oral Consumption Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Oral Consumption Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Inhalation / Smoking / Vaping Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Inhalation / Smoking / Vaping Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Inhalation / Smoking / Vaping Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Topical Application Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Topical Application Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Topical Application Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Medical & Recreational Marijuana Market Size, by Usage, 2017-2032 (USD Million)
TABLE 44. Global Medical Use Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Medical Use Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Medical Use Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Recreational Use Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Recreational Use Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Recreational Use Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Medical & Recreational Marijuana Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Asia-Pacific Medical & Recreational Marijuana Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Asia-Pacific Medical & Recreational Marijuana Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 53. Asia-Pacific Medical & Recreational Marijuana Market Size, by THC / CBD Content, 2017-2032 (USD Million)
TABLE 54. Asia-Pacific Medical & Recreational Marijuana Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 55. Asia-Pacific Medical & Recreational Marijuana Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 56. Asia-Pacific Medical & Recreational Marijuana Market Size, by Usage, 2017-2032 (USD Million)
TABLE 57. North America Medical & Recreational Marijuana Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. North America Medical & Recreational Marijuana Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 59. North America Medical & Recreational Marijuana Market Size, by THC / CBD Content, 2017-2032 (USD Million)
TABLE 60. North America Medical & Recreational Marijuana Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 61. North America Medical & Recreational Marijuana Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 62. North America Medical & Recreational Marijuana Market Size, by Usage, 2017-2032 (USD Million)
TABLE 63. Latin America Medical & Recreational Marijuana Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Latin America Medical & Recreational Marijuana Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 65. Latin America Medical & Recreational Marijuana Market Size, by THC / CBD Content, 2017-2032 (USD Million)
TABLE 66. Latin America Medical & Recreational Marijuana Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 67. Latin America Medical & Recreational Marijuana Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 68. Latin America Medical & Recreational Marijuana Market Size, by Usage, 2017-2032 (USD Million)
TABLE 69. Europe Medical & Recreational Marijuana Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Europe Medical & Recreational Marijuana Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 71. Europe Medical & Recreational Marijuana Market Size, by THC / CBD Content, 2017-2032 (USD Million)
TABLE 72. Europe Medical & Recreational Marijuana Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 73. Europe Medical & Recreational Marijuana Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 74. Europe Medical & Recreational Marijuana Market Size, by Usage, 2017-2032 (USD Million)
TABLE 75. Middle East Medical & Recreational Marijuana Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Middle East Medical & Recreational Marijuana Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 77. Middle East Medical & Recreational Marijuana Market Size, by THC / CBD Content, 2017-2032 (USD Million)
TABLE 78. Middle East Medical & Recreational Marijuana Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 79. Middle East Medical & Recreational Marijuana Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 80. Middle East Medical & Recreational Marijuana Market Size, by Usage, 2017-2032 (USD Million)
TABLE 81. Africa Medical & Recreational Marijuana Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Africa Medical & Recreational Marijuana Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 83. Africa Medical & Recreational Marijuana Market Size, by THC / CBD Content, 2017-2032 (USD Million)
TABLE 84. Africa Medical & Recreational Marijuana Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 85. Africa Medical & Recreational Marijuana Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 86. Africa Medical & Recreational Marijuana Market Size, by Usage, 2017-2032 (USD Million)
TABLE 87. Global Medical & Recreational Marijuana Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. ASEAN Medical & Recreational Marijuana Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. ASEAN Medical & Recreational Marijuana Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 90. ASEAN Medical & Recreational Marijuana Market Size, by THC / CBD Content, 2017-2032 (USD Million)
TABLE 91. ASEAN Medical & Recreational Marijuana Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 92. ASEAN Medical & Recreational Marijuana Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 93. ASEAN Medical & Recreational Marijuana Market Size, by Usage, 2017-2032 (USD Million)
TABLE 94. GCC Medical & Recreational Marijuana Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. GCC Medical & Recreational Marijuana Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 96. GCC Medical & Recreational Marijuana Market Size, by THC / CBD Content, 2017-2032 (USD Million)
TABLE 97. GCC Medical & Recreational Marijuana Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 98. GCC Medical & Recreational Marijuana Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 99. GCC Medical & Recreational Marijuana Market Size, by Usage, 2017-2032 (USD Million)
TABLE 100. European Union Medical & Recreational Marijuana Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. European Union Medical & Recreational Marijuana Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 102. European Union Medical & Recreational Marijuana Market Size, by THC / CBD Content, 2017-2032 (USD Million)
TABLE 103. European Union Medical & Recreational Marijuana Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 104. European Union Medical & Recreational Marijuana Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 105. European Union Medical & Recreational Marijuana Market Size, by Usage, 2017-2032 (USD Million)
TABLE 106. BRICS Medical & Recreational Marijuana Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. BRICS Medical & Recreational Marijuana Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 108. BRICS Medical & Recreational Marijuana Market Size, by THC / CBD Content, 2017-2032 (USD Million)
TABLE 109. BRICS Medical & Recreational Marijuana Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 110. BRICS Medical & Recreational Marijuana Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 111. BRICS Medical & Recreational Marijuana Market Size, by Usage, 2017-2032 (USD Million)
TABLE 112. G7 Medical & Recreational Marijuana Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. G7 Medical & Recreational Marijuana Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 114. G7 Medical & Recreational Marijuana Market Size, by THC / CBD Content, 2017-2032 (USD Million)
TABLE 115. G7 Medical & Recreational Marijuana Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 116. G7 Medical & Recreational Marijuana Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 117. G7 Medical & Recreational Marijuana Market Size, by Usage, 2017-2032 (USD Million)
TABLE 118. NATO Medical & Recreational Marijuana Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. NATO Medical & Recreational Marijuana Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 120. NATO Medical & Recreational Marijuana Market Size, by THC / CBD Content, 2017-2032 (USD Million)
TABLE 121. NATO Medical & Recreational Marijuana Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 122. NATO Medical & Recreational Marijuana Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 123. NATO Medical & Recreational Marijuana Market Size, by Usage, 2017-2032 (USD Million)
TABLE 124. Global Medical & Recreational Marijuana Market Size, by Country, 2017-2032 (USD Million)
TABLE 125. United States Medical & Recreational Marijuana Market Size, 2017-2032 (USD Million)
TABLE 126. United States Medical & Recreational Marijuana Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 127. United States Medical & Recreational Marijuana Market Size, by THC / CBD Content, 2017-2032 (USD Million)
TABLE 128. United States Medical & Recreational Marijuana Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 129. United States Medical & Recreational Marijuana Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 130. United States Medical & Recreational Marijuana Market Size, by Usage, 2017-2032 (USD Million)
TABLE 131. Canada Medical & Recreational Marijuana Market Size, 2017-2032 (USD Million)
TABLE 132. Canada Medical & Recreational Marijuana Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 133. Canada Medical & Recreational Marijuana Market Size, by THC / CBD Content, 2017-2032 (USD Million)
TABLE 134. Canada Medical & Recreational Marijuana Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 135. Canada Medical & Recreational Marijuana Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 136. Canada Medical & Recreational Marijuana Market Size, by Usage, 2017-2032 (USD Million)
TABLE 137. Mexico Medical & Recreational Marijuana Market Size, 2017-2032 (USD Million)
TABLE 138. Mexico Medical & Recreational Marijuana Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 139. Mexico Medical & Recreational Marijuana Market Size, by THC / CBD Content, 2017-2032 (USD Million)
TABLE 140. Mexico Medical & Recreational Marijuana Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 141. Mexico Medical & Recreational Marijuana Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 142. Mexico Medical & Recreational Marijuana Market Size, by Usage, 2017-2032 (USD Million)
TABLE 143. Brazil Medical & Recreational Marijuana Market Size, 2017-2032 (USD Million)
TABLE 144. Brazil Medical & Recreational Marijuana Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 145. Brazil Medical & Recreational Marijuana Market Size, by THC / CBD Content, 2017-2032 (USD Million)
TABLE 146. Brazil Medical & Recreational Marijuana Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 147. Brazil Medical & Recreational Marijuana Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 148. Brazil Medical & Recreational Marijuana Market Size, by Usage, 2017-2032 (USD Million)
TABLE 149. United Kingdom Medical & Recreational Marijuana Market Size, 2017-2032 (USD Million)
TABLE 150. United Kingdom Medical & Recreational Marijuana Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 151. United Kingdom Medical & Recreational Marijuana Market Size, by THC / CBD Content, 2017-2032 (USD Million)
TABLE 152. United Kingdom Medical & Recreational Marijuana Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 153. United Kingdom Medical & Recreational Marijuana Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 154. United Kingdom Medical & Recreational Marijuana Market Size, by Usage, 2017-2032 (USD Million)
TABLE 155. Germany Medical & Recreational Marijuana Market Size, 2017-2032 (USD Million)
TABLE 156. Germany Medical & Recreational Marijuana Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 157. Germany Medical & Recreational Marijuana Market Size, by THC / CBD Content, 2017-2032 (USD Million)
TABLE 158. Germany Medical & Recreational Marijuana Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 159. Germany Medical & Recreational Marijuana Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 160. Germany Medical & Recreational Marijuana Market Size, by Usage, 2017-2032 (USD Million)
TABLE 161. France Medical & Recreational Marijuana Market Size, 2017-2032 (USD Million)
TABLE 162. France Medical & Recreational Marijuana Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 163. France Medical & Recreational Marijuana Market Size, by THC / CBD Content, 2017-2032 (USD Million)
TABLE 164. France Medical & Recreational Marijuana Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 165. France Medical & Recreational Marijuana Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 166. France Medical & Recreational Marijuana Market Size, by Usage, 2017-2032 (USD Million)
TABLE 167. Russia Medical & Recreational Marijuana Market Size, 2017-2032 (USD Million)
TABLE 168. Russia Medical & Recreational Marijuana Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 169. Russia Medical & Recreational Marijuana Market Size, by THC / CBD Content, 2017-2032 (USD Million)
TABLE 170. Russia Medical & Recreational Marijuana Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 171. Russia Medical & Recreational Marijuana Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 172. Russia Medical & Recreational Marijuana Market Size, by Usage, 2017-2032 (USD Million)
TABLE 173. Italy Medical & Recreational Marijuana Market Size, 2017-2032 (USD Million)
TABLE 174. Italy Medical & Recreational Marijuana Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 175. Italy Medical & Recreational Marijuana Market Size, by THC / CBD Content, 2017-2032 (USD Million)
TABLE 176. Italy Medical & Recreational Marijuana Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 177. Italy Medical & Recreational Marijuana Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 178. Italy Medical & Recreational Marijuana Market Size, by Usage, 2017-2032 (USD Million)
TABLE 179. Spain Medical & Recreational Marijuana Market Size, 2017-2032 (USD Million)
TABLE 180. Spain Medical & Recreational Marijuana Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 181. Spain Medical & Recreational Marijuana Market Size, by THC / CBD Content, 2017-2032 (USD Million)
TABLE 182. Spain Medical & Recreational Marijuana Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 183. Spain Medical & Recreational Marijuana Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 184. Spain Medical & Recreational Marijuana Market Size, by Usage, 2017-2032 (USD Million)
TABLE 185. China Medical & Recreational Marijuana Market Size, 2017-2032 (USD Million)
TABLE 186. China Medical & Recreational Marijuana Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 187. China Medical & Recreational Marijuana Market Size, by THC / CBD Content, 2017-2032 (USD Million)
TABLE 188. China Medical & Recreational Marijuana Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 189. China Medical & Recreational Marijuana Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 190. China Medical & Recreational Marijuana Market Size, by Usage, 2017-2032 (USD Million)
TABLE 191. India Medical & Recreational Marijuana Market Size, 2017-2032 (USD Million)
TABLE 192. India Medical & Recreational Marijuana Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 193. India Medical & Recreational Marijuana Market Size, by THC / CBD Content, 2017-2032 (USD Million)
TABLE 194. India Medical & Recreational Marijuana Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 195. India Medical & Recreational Marijuana Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 196. India Medical & Recreational Marijuana Market Size, by Usage, 2017-2032 (USD Million)
TABLE 197. Japan Medical & Recreational Marijuana Market Size, 2017-2032 (USD Million)
TABLE 198. Japan Medical & Recreational Marijuana Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 199. Japan Medical & Recreational Marijuana Market Size, by THC / CBD Content, 2017-2032 (USD Million)
TABLE 200. Japan Medical & Recreational Marijuana Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 201. Japan Medical & Recreational Marijuana Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 202. Japan Medical & Recreational Marijuana Market Size, by Usage, 2017-2032 (USD Million)
TABLE 203. Australia Medical & Recreational Marijuana Market Size, 2017-2032 (USD Million)
TABLE 204. Australia Medical & Recreational Marijuana Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 205. Australia Medical & Recreational Marijuana Market Size, by THC / CBD Content, 2017-2032 (USD Million)
TABLE 206. Australia Medical & Recreational Marijuana Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 207. Australia Medical & Recreational Marijuana Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 208. Australia Medical & Recreational Marijuana Market Size, by Usage, 2017-2032 (USD Million)
TABLE 209. South Korea Medical & Recreational Marijuana Market Size, 2017-2032 (USD Million)
TABLE 210. South Korea Medical & Recreational Marijuana Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 211. South Korea Medical & Recreational Marijuana Market Size, by THC / CBD Content, 2017-2032 (USD Million)
TABLE 212. South Korea Medical & Recreational Marijuana Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 213. South Korea Medical & Recreational Marijuana Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 214. South Korea Medical & Recreational Marijuana Market Size, by Usage, 2017-2032 (USD Million)
TABLE 215. Global Medical & Recreational Marijuana Market Share, by Key Player, 2025
TABLE 216. Global Medical & Recreational Marijuana Market, Key Experts

Companies Mentioned

  • Aurora Cannabis Inc.
  • Breathe Life Sciences
  • Cannabis Sativa, Inc.
  • Canopy Growth Corporation
  • Cresco Labs
  • Cronos Group Inc.
  • Curaleaf Holdings, Inc.
  • Green Relief Inc.
  • Green Thumb Industries Inc.
  • GW Pharmaceuticals plc
  • Medical Marijuana, Inc.
  • MedMen Enterprises Inc.
  • MedReleaf Corporation
  • Organigram Global Inc.
  • STENOCARE AB
  • TerrAscend Corp.
  • Tilray Brands Inc.
  • Trulieve Cannabis Corporation
  • Vivo Cannabis Inc.
  • Zenabis Global Inc.

Related Topics

Related Reports

Marijuana Market - Global Forecast 2026-2032 - Product Image

Marijuana Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From
Legal Marijuana Market - Global Forecast 2026-2032 - Product Image

Legal Marijuana Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
North America Legal Cannabis Market Size, Share, Trends and Forecast by Products Derived, Distribution Channel, and Country, 2026-2034 - Product Image

North America Legal Cannabis Market Size, Share, Trends and Forecast by Products Derived, Distribution Channel, and Country, 2026-2034

  • Report
  • 149 Pages
  • North America
From
Cannabis Market Outlook - Forecast Trends, Market Size, Share and Growth Analysis Report 2025-2034 - Product Image

Cannabis Market Outlook - Forecast Trends, Market Size, Share and Growth Analysis Report 2025-2034

  • Report
  • 400 Pages
  • Global
From
Cannabis Market in the US 2026-2030 - Product Image

Cannabis Market in the US 2026-2030

  • Report
  • 181 Pages
  • United States
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.